Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCS. [PDF]
Steiner MA +8 more
europepmc +1 more source
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease). [PDF]
Davies EH, Johnston J, Toro C, Tifft CJ.
europepmc +1 more source
3D bioprinted neural scaffolds: a transformative avenue for GM2 gangliosidosis therapy. [PDF]
Sheikh M +4 more
europepmc +1 more source
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial. [PDF]
Eichler F +35 more
europepmc +1 more source
VaProS: a database-integration approach for protein/genome information retrieval [PDF]
core +1 more source
Correction: Vyas et al. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 14611. [PDF]
Vyas M +9 more
europepmc +1 more source
Elevated plasma chitotriosidase activity in various lysosomal storage disorders [PDF]
Aerts, J.M.F.G. (Johannes) +9 more
core +1 more source
Brainstem Substructure Atrophy in Late-Onset GM2-Gangliosidosis Imaging Using Automated Segmentation. [PDF]
Rowe OE +5 more
europepmc +1 more source
Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay-Sachs and Sandhoff diseases. [PDF]
Lewis CJ +5 more
europepmc +1 more source
Systematic review of autosomal recessive ataxias and proposal for a classification [PDF]
Christopher J. Klein +3 more
core +1 more source

